SG11201913520YA - Novel intermediates useful for the synthesis of aminopyrimidine derivatives, process for preparing the same, and process for preparing aminopyrimidine derivatives using the same - Google Patents
Novel intermediates useful for the synthesis of aminopyrimidine derivatives, process for preparing the same, and process for preparing aminopyrimidine derivatives using the sameInfo
- Publication number
- SG11201913520YA SG11201913520YA SG11201913520YA SG11201913520YA SG11201913520YA SG 11201913520Y A SG11201913520Y A SG 11201913520YA SG 11201913520Y A SG11201913520Y A SG 11201913520YA SG 11201913520Y A SG11201913520Y A SG 11201913520YA SG 11201913520Y A SG11201913520Y A SG 11201913520YA
- Authority
- SG
- Singapore
- Prior art keywords
- preparing
- same
- aminopyrimidine derivatives
- synthesis
- novel intermediates
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
- C07D265/32—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20170096220 | 2017-07-28 | ||
PCT/KR2018/008381 WO2019022486A1 (en) | 2017-07-28 | 2018-07-25 | Novel intermediates useful for the synthesis of aminopyrimidine derivatives, process for preparing the same, and process for preparing aminopyrimidine derivatives using the same |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201913520YA true SG11201913520YA (en) | 2020-02-27 |
Family
ID=65040817
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201913520YA SG11201913520YA (en) | 2017-07-28 | 2018-07-25 | Novel intermediates useful for the synthesis of aminopyrimidine derivatives, process for preparing the same, and process for preparing aminopyrimidine derivatives using the same |
Country Status (26)
Country | Link |
---|---|
US (1) | US10858353B2 (en) |
EP (1) | EP3658553B1 (en) |
JP (1) | JP7216704B2 (en) |
KR (1) | KR20190013554A (en) |
CN (1) | CN111032650A (en) |
AU (1) | AU2018308039B2 (en) |
BR (1) | BR112020001396A2 (en) |
CA (1) | CA3069408A1 (en) |
CO (1) | CO2020000595A2 (en) |
DK (1) | DK3658553T3 (en) |
EA (1) | EA038856B1 (en) |
ES (1) | ES2923278T3 (en) |
HR (1) | HRP20220848T1 (en) |
HU (1) | HUE059501T2 (en) |
IL (1) | IL271974B (en) |
LT (1) | LT3658553T (en) |
MA (1) | MA49703A (en) |
PH (1) | PH12020500070A1 (en) |
PL (1) | PL3658553T3 (en) |
PT (1) | PT3658553T (en) |
RS (1) | RS63497B1 (en) |
SA (1) | SA520411120B1 (en) |
SG (1) | SG11201913520YA (en) |
SI (1) | SI3658553T1 (en) |
UA (1) | UA125664C2 (en) |
WO (1) | WO2019022486A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020230091A1 (en) | 2019-05-14 | 2020-11-19 | Janssen Biotech, Inc. | Combination therapies with bispecific anti-egfr/c-met antibodies and third generation egfr tyrosine kinase inhibitors |
US11850248B2 (en) | 2019-05-14 | 2023-12-26 | Yuhan Corporation | Therapies with 3rd generation EGFR tyrosine kinase inhibitors |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101663637B1 (en) * | 2009-11-13 | 2016-10-07 | 제노스코 | Kinase inhibitors |
CN105461695B (en) * | 2014-09-29 | 2018-03-27 | 齐鲁制药有限公司 | Pyrimidine or pyrrolotriazine derivatives and its production and use |
PT3207035T (en) * | 2014-10-13 | 2020-02-19 | Yuhan Corp | Compounds and compositions for modulating egfr mutant kinase activities |
CN104788427B (en) * | 2015-02-05 | 2017-05-31 | 上海泓博智源医药股份有限公司 | 3 (2 pyrimdinyl-amino) phenylacryloyl amine compounds and its application |
WO2016173438A1 (en) * | 2015-04-29 | 2016-11-03 | 南京明德新药研发股份有限公司 | Fused-ring or tricyclic aryl pyrimidine compound used as kinase inhibitor |
WO2017027768A1 (en) * | 2015-08-13 | 2017-02-16 | The Broad Institute, Inc. | Compositions and methods for treating tuberculosis |
PT3658547T (en) * | 2017-07-28 | 2023-10-20 | Yuhan Corp | Intermediates useful for the synthesis of a selective inhibitor against protein kinase and processes for preparing the same |
-
2018
- 2018-07-25 US US16/633,695 patent/US10858353B2/en active Active
- 2018-07-25 LT LTEPPCT/KR2018/008381T patent/LT3658553T/en unknown
- 2018-07-25 UA UAA202001305A patent/UA125664C2/en unknown
- 2018-07-25 ES ES18838173T patent/ES2923278T3/en active Active
- 2018-07-25 DK DK18838173.5T patent/DK3658553T3/en active
- 2018-07-25 IL IL271974A patent/IL271974B/en unknown
- 2018-07-25 RS RS20220706A patent/RS63497B1/en unknown
- 2018-07-25 BR BR112020001396-0A patent/BR112020001396A2/en unknown
- 2018-07-25 EP EP18838173.5A patent/EP3658553B1/en active Active
- 2018-07-25 MA MA049703A patent/MA49703A/en unknown
- 2018-07-25 HU HUE18838173A patent/HUE059501T2/en unknown
- 2018-07-25 PT PT188381735T patent/PT3658553T/en unknown
- 2018-07-25 SG SG11201913520YA patent/SG11201913520YA/en unknown
- 2018-07-25 WO PCT/KR2018/008381 patent/WO2019022486A1/en active Application Filing
- 2018-07-25 AU AU2018308039A patent/AU2018308039B2/en active Active
- 2018-07-25 CA CA3069408A patent/CA3069408A1/en active Pending
- 2018-07-25 EA EA202090385A patent/EA038856B1/en unknown
- 2018-07-25 CN CN201880049025.7A patent/CN111032650A/en active Pending
- 2018-07-25 KR KR1020180086377A patent/KR20190013554A/en active IP Right Grant
- 2018-07-25 JP JP2020503944A patent/JP7216704B2/en active Active
- 2018-07-25 HR HRP20220848TT patent/HRP20220848T1/en unknown
- 2018-07-25 SI SI201830722T patent/SI3658553T1/en unknown
- 2018-07-25 PL PL18838173.5T patent/PL3658553T3/en unknown
-
2020
- 2020-01-09 PH PH12020500070A patent/PH12020500070A1/en unknown
- 2020-01-20 CO CONC2020/0000595A patent/CO2020000595A2/en unknown
- 2020-01-22 SA SA520411120A patent/SA520411120B1/en unknown
Also Published As
Publication number | Publication date |
---|---|
PH12020500070A1 (en) | 2020-12-07 |
CN111032650A (en) | 2020-04-17 |
LT3658553T (en) | 2022-09-12 |
AU2018308039A1 (en) | 2020-01-30 |
CO2020000595A2 (en) | 2020-05-05 |
IL271974A (en) | 2020-02-27 |
JP2020528437A (en) | 2020-09-24 |
CA3069408A1 (en) | 2019-01-31 |
KR20190013554A (en) | 2019-02-11 |
US10858353B2 (en) | 2020-12-08 |
AU2018308039B2 (en) | 2022-04-14 |
DK3658553T3 (en) | 2022-07-25 |
ES2923278T3 (en) | 2022-09-26 |
UA125664C2 (en) | 2022-05-11 |
EP3658553A4 (en) | 2021-04-21 |
PL3658553T3 (en) | 2022-10-10 |
RS63497B1 (en) | 2022-09-30 |
BR112020001396A2 (en) | 2020-08-11 |
HRP20220848T1 (en) | 2022-10-14 |
MA49703A (en) | 2021-04-21 |
SA520411120B1 (en) | 2022-08-25 |
WO2019022486A1 (en) | 2019-01-31 |
PT3658553T (en) | 2022-09-23 |
IL271974B (en) | 2022-08-01 |
EA038856B1 (en) | 2021-10-28 |
HUE059501T2 (en) | 2022-11-28 |
JP7216704B2 (en) | 2023-02-01 |
EP3658553A1 (en) | 2020-06-03 |
EP3658553B1 (en) | 2022-06-15 |
SI3658553T1 (en) | 2022-10-28 |
US20200207750A1 (en) | 2020-07-02 |
EA202090385A1 (en) | 2020-09-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3645529A4 (en) | Process for preparing lifitegrast and intermediates thereof | |
EP3694499A4 (en) | Novel process for the preparation of lifitegrast | |
EP3617195A4 (en) | Novel tetrahydronaphthyl urea derivatives | |
EP3421502C0 (en) | Process for the production of thermally modified starch | |
IL292429B2 (en) | Improved process for preparing aminopyrimidine derivatives | |
EP3265455A4 (en) | Chemical process for preparing pyrimidine derivatives and intermediates thereof | |
IL271974A (en) | Novel intermediates useful for the synthesis of aminopyrimidine derivatives, process for preparing the same, and process for preparing aminopyrimidine derivatives using the same | |
ZA201907517B (en) | Process for the preparation of piperazine ring for the synthesis of pyrazinocarbazole derivatives | |
PT3759082T (en) | Process for the synthesis of 6-chloromethyluracil | |
HK1255476A1 (en) | Process for the synthesis of intermediates of nebivolol | |
IN2015CH02092A (en) | ||
IL259332A (en) | Process for the synthesis of intermediates useful for preparing 1,3,4-triazine derivatives | |
IS2977B (en) | Process for the preparation of intermediates useful in the synthesis of eluxadoline | |
PL3609877T3 (en) | Process for the synthesis of firocoxib | |
PL3704100T3 (en) | Novel process for the preparation tavaborole and its intermediates | |
LT3713939T (en) | Improved process for the synthesis of linker-drug vc-seco | |
RS63067B1 (en) | Process for the preparation of piperazine ring for the synthesis of pyrazinocarbazole derivatives | |
PL3612534T3 (en) | Process for the preparation of piperazine ring for the synthesis of pyrazinocarbazole derivatives | |
MX2018001296A (en) | Process for the synthesis of ravidasvir. | |
HUP1500451A2 (en) | Processes for the preparation of 1,4,7-triaza-cyclononane derivatives and intermediates |